Exploring predictors of dysphagia in survivors of head and neck cancer: A cross‑sectional study
Metadatos
Mostrar el registro completo del ítemAutor
López-Fernández, Maria Dolores; Fernández Lao, Carolina; Ruíz Martínez, Alba María; Fernández Gualda, Miguel Ángel; Lozano Lozano, Mario; Ortiz Comino, Lucía; Galiano Castillo, NoeliaEditorial
Springer Nature
Materia
Head and Neck Neoplasms Deglutition Disorders Trismus
Fecha
2024-02-17Referencia bibliográfica
López-Fernández, M.D., Fernández-Lao, C., Ruíz-Martínez, A.M. et al. Exploring predictors of dysphagia in survivors of head and neck cancer: A cross-sectional study. Support Care Cancer 32, 162 (2024). https://doi.org/10.1007/s00520-024-08358-w
Patrocinador
Funding for open access publishing: Universidad de Granada/CBUA.; Consejería de Salud, Junta de Andalucía (PI-0187–2021 and PI-0171–2020); European Regional Development Fund (ERDF-FEDER)Resumen
Purpose To evaluate the prevalence of dysphagia in survivors of head and neck cancer (sHNC) and to identify the predictors
contributing to the development of dysphagia.
Methods We enrolled 62 sHNC in a cross-sectional study to check the prevalence of dysphagia in sHNC and to evaluate
which factors were influencing the presence of this side effect. Besides dysphagia, sociodemographic and clinical characteristics,
oral symptoms, maximal mouth opening (MMO), sleep quality and physical condition were evaluated, and a linear
regression analysis was performed to verify which of these outcomes impact dysphagia.
Results Among all the sHNC, 85.5% presented dysphagia. The linear regression analysis confirmed that 44.9% of the variance
in dysphagia was determined by coughing, MMO and sleep quality, being MMO the most powerful predictor, followed
by coughing and sleep quality.
Conclusion Dysphagia affected the great majority of sHNC. Moreover, symptoms as coughing, reduced MMO and sleep
disorders may act as predictors contributing to the development of dysphagia. Our results emphasize the importance of an
early and proper identification of the symptoms as well as an adequate treatment strategy to address the cluster of symptoms
that sHNC undergo.